FDA Approved: GLIPIZIDE AND METFORMIN HCL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for GLIPIZIDE AND METFORMIN HCL, a fixed-dose combination tablet, by Heritage Pharmaceuticals (Avet) for marketing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLIPIZIDE AND METFORMIN HCL (GLIPIZIDE AND METFORMIN HCL)

Snippet

SUPPL AP for GLIPIZIDE AND METFORMIN HCL (GLIPIZIDE AND METFORMIN HCL)